The EML4‐ALK fusion was shown to be variant 1 via comparative western blotting of the same variant harbored by the commonly used ALK‐rearranged lung cancer cell line NCI‐H3122 (Fig. 1D). The gene discussed is ALK; the disease is lung carcinoma.